Kai Yang

2.4k total citations
85 papers, 1.3k citations indexed

About

Kai Yang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Kai Yang has authored 85 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Kai Yang's work include Pulmonary Hypertension Research and Treatments (30 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Nitric Oxide and Endothelin Effects (7 papers). Kai Yang is often cited by papers focused on Pulmonary Hypertension Research and Treatments (30 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Nitric Oxide and Endothelin Effects (7 papers). Kai Yang collaborates with scholars based in China, United States and Canada. Kai Yang's co-authors include Wenju Lu, Jian Wang, Yuqin Chen, Jiang Qian, Xiangdong Chen, Jing Wu, Nanshan Zhong, Ning Lai, Pixin Ran and Ying-Sheng Cheng and has published in prestigious journals such as PLoS ONE, Journal of Power Sources and Scientific Reports.

In The Last Decade

Kai Yang

76 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Yang China 24 493 466 228 157 151 85 1.3k
Longkun Li China 27 258 0.5× 635 1.4× 355 1.6× 142 0.9× 100 0.7× 101 1.9k
Xing Chen China 19 189 0.4× 836 1.8× 130 0.6× 88 0.6× 56 0.4× 112 1.6k
Yanira Riffo‐Vasquez United Kingdom 19 316 0.6× 298 0.6× 108 0.5× 445 2.8× 126 0.8× 43 1.4k
David Lamb United Kingdom 24 199 0.4× 340 0.7× 192 0.8× 211 1.3× 38 0.3× 70 1.6k
Chunhui Liu China 20 171 0.3× 472 1.0× 189 0.8× 76 0.5× 23 0.2× 86 1.4k
Ping Han China 22 487 1.0× 216 0.5× 478 2.1× 71 0.5× 31 0.2× 89 1.4k
Xinrong Li China 16 269 0.5× 374 0.8× 123 0.5× 119 0.8× 26 0.2× 61 1.1k
Naohiro Nomura Japan 27 353 0.7× 1.2k 2.5× 189 0.8× 157 1.0× 19 0.1× 61 1.9k
Kai‐Li Liang Taiwan 25 241 0.5× 230 0.5× 566 2.5× 273 1.7× 373 2.5× 92 1.8k
Hwa Young Lee South Korea 19 245 0.5× 289 0.6× 112 0.5× 201 1.3× 50 0.3× 72 1.2k

Countries citing papers authored by Kai Yang

Since Specialization
Citations

This map shows the geographic impact of Kai Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Yang more than expected).

Fields of papers citing papers by Kai Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Yang. The network helps show where Kai Yang may publish in the future.

Co-authorship network of co-authors of Kai Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Yang. A scholar is included among the top collaborators of Kai Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Yang. Kai Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Chao, et al.. (2025). Development of tanshinone IIA chitosan nanoparticles via chitosan solid dispersion for improving the therapeutical effects. Journal of Drug Delivery Science and Technology. 107. 106752–106752. 1 indexed citations
2.
Liu, Sheng, et al.. (2025). PFKFB3 confers cisplatin resistance in gastric cancer by inhibiting ferroptosis through SLC7A11/xCT dephosphorylation. International Immunopharmacology. 159. 114914–114914. 3 indexed citations
3.
4.
Zhang, Chenting, Tingting Zhang, Wenju Lu, et al.. (2023). Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats. British Journal of Pharmacology. 180(16). 2102–2119. 8 indexed citations
5.
6.
7.
Yuan, Hong, et al.. (2023). The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. PLoS ONE. 18(10). e0293275–e0293275. 3 indexed citations
8.
Wang, Jing, Qiuyu Zheng, Qing Zhang, et al.. (2023). Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells. American Journal of Physiology-Cell Physiology. 325(4). C1058–C1072. 3 indexed citations
9.
Han, Jingxia, Jing Jin, Ting Wu, et al.. (2023). Polydopamine-loaded prunetin nanomaterials activate DRD2 to reduce UV-induced inflammation by stabilizing and promoting Nrf2 nuclear translocation. Acta Biomaterialia. 169. 556–565. 7 indexed citations
10.
Chen, Jiyuan, Jing Liao, Ziyi Wang, et al.. (2022). Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension. Thrombosis Research. 218. 52–63. 27 indexed citations
11.
Wang, Ting, Kai Yang, Chenting Zhang, et al.. (2022). Respiratory Microbiome Profile of Pediatric Pulmonary Hypertension Patients Associated With Congenital Heart Disease. Hypertension. 80(1). 214–226. 3 indexed citations
12.
Yang, Kai, Lele Cui, Xueyu Chen, et al.. (2022). Decreased Vessel Density in Retinal Capillary Plexus and Thinner Ganglion Cell Complex Associated With Cognitive Impairment. Frontiers in Aging Neuroscience. 14. 872466–872466. 9 indexed citations
13.
Zhan, Shi, Dajun Jiang, Ming Ling, et al.. (2021). Fixation effects of different types of cannulated screws on vertical femoral neck fracture: A finite element analysis and experimental study. Medical Engineering & Physics. 97(1). 32–39. 11 indexed citations
14.
Qian, Jiang, C. Liu, Shiyun Liu, et al.. (2020). Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats. British Journal of Pharmacology. 178(1). 203–216. 40 indexed citations
15.
Liu, Jingjing, et al.. (2020). Polysplenia syndrome with a rare variation between the common hepatic artery and the superior mesenteric artery in adults. Archives of Medical Science. 16(5). 1263–1266. 2 indexed citations
16.
Huang, Junyi, Wenju Lu, Yuqin Chen, et al.. (2019). Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition. American Journal of Respiratory Cell and Molecular Biology. 62(1). 49–60. 23 indexed citations
17.
Wang, Jian, Fei Liu, Yuan Liang, et al.. (2019). Non-inflammatory emphysema induced by NO2 chronic exposure and intervention with demethylation 5-Azacytidine. Life Sciences. 221. 121–129. 8 indexed citations
18.
Lu, Wenju, Kai Yang, Qiuyu Zheng, et al.. (2018). Establishment and evaluation of chronic obstructive pulmonary disease model by chronic exposure to motor vehicle exhaust combined with lipopolysaccharide instillation. Experimental Physiology. 103(11). 1532–1542. 7 indexed citations
19.
Yang, Kai, Wenju Lu, Jiang Qian, et al.. (2015). Peroxisome Proliferator–Activated Receptor γ–Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1–Dependent Mechanism. American Journal of Respiratory Cell and Molecular Biology. 53(6). 882–892. 28 indexed citations
20.
Yang, Kai, et al.. (2012). Inhibitory Effect of Ginsenoside Rg3 on Growth，Metastasis and Expression of TAMs in Mice Lung Adenocarcinoma. Zhongliu fangzhi yanjiu. 39(12). 1411–1415.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Longkun Li Breakdown of academic impact, for papers by Xing Chen Breakdown of academic impact, for papers by Yanira Riffo‐Vasquez Breakdown of academic impact, for papers by David Lamb Breakdown of academic impact, for papers by Chunhui Liu Breakdown of academic impact, for papers by Ping Han Breakdown of academic impact, for papers by Xinrong Li Breakdown of academic impact, for papers by Naohiro Nomura Breakdown of academic impact, for papers by Kai‐Li Liang Breakdown of academic impact, for papers by Hwa Young Lee
Rankless by CCL
2026